Date Title Description PDF
25 Feb 2025 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
07 Feb 2025 On P&L The Company informs on some of the results expected by the market consensus Download
07 Nov 2024 On P&L The Company releases the press release related to the first nine months 2024 financial results Download
07 Nov 2024 On P&L The Company releases the first nine months 2024 financial results presentation Download
24 Oct 2024 On corporate transactions ROVI completes the strategic review of its CDMO business Download

Pages

Date Title Description PDF
18 Nov 2025 On business and financial situation The Company releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development Download
02 Oct 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2025 Download
04 Jul 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2025 Download
03 Jul 2025 Other relevant information The Company informs about the dividends payment.  Download
18 Jun 2025 Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download

Pages

Date Title Description PDF
10 May 2018 Otros sobre negocio y situación financiera Update pivotal PRISMA-3 study of DORIA® (Risperidone ISM®) Download
25 Apr 2018 Información sobre resultados ROVI releases the press release related to the 2018 first quarter financial results Download
25 Apr 2018 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI informs about the call for the 2018 Ordinary General Shareholders Meeting Download
25 Apr 2018 Información sobre resultados ROVI releases the 2018 first quarter results presentation Download
04 Apr 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2018 Download

Pages